KB

Karunamoorthy Bhuvaneswari

Active Director Director DIN 08765537
DIN 08765537 First appointment Jun 2020 Primary industry Research & Development
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2020
Shareholding value β€’β€’β€’β€’ Premium profile

About Karunamoorthy Bhuvaneswari

Data last updated:

Karunamoorthy Bhuvaneswari is a Director at Inducer Biotech Private Limited (since 2020). The company operates in Research & Development.

DIN 08765537
Primary Designation Director
Industry Research & Development
First Appointment 17 Jun 2020
Oldest Company Age 6 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Inducer Biotech Private Limited U73100TN2020PTC135873
Director17 Jun 20202020Active

Board colleagues of Karunamoorthy Bhuvaneswari

NameDINCompanyDesignation
Sakunthala10298343Inducer Biotech Private LimitedDirector

Directorship timeline

Open interactive timeline →
Inducer Biotech Private Limited
Premium access

Shareholding and investment profile for Karunamoorthy Bhuvaneswari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Karunamoorthy Bhuvaneswari

Karunamoorthy Bhuvaneswari currently holds 1 directorship: Inducer Biotech Private Limited (Director, since 17 Jun 2020).

Karunamoorthy Bhuvaneswari was first appointed on 17 Jun 2020 as Director at Inducer Biotech Private Limited.

The current boards of Karunamoorthy Bhuvaneswari's companies include Sakunthala (Inducer Biotech Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available